Income Taxes - Narrative (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Income Tax Disclosure [Line Items] | ||
Current income tax expense (benefit) | $ 0 | $ 0 |
Deferred income tax expense (benefit) | 0 | 0 |
Increase (decrease) in valuation allowance, deferred tax assets | 18,200,000 | 64,200,000 |
Deferred capitalized start up expense net of amortization | 100,000 | 300,000 |
Deferred income tax amortization | 1,800,000 | 1,700,000 |
Research and development tax credit carryforwards | 4,827,000 | 5,034,000 |
Decrease in deferred tax asset | 44,900,000 | |
Federal | ||
Income Tax Disclosure [Line Items] | ||
Net operating loss carryforwards | 1,230,700,000 | 1,224,500,000 |
Net operating loss carryforwards indefinitely due to tax cut and jobs act | 648,700,000 | |
Research and development tax credit carryforwards | 2,500,000 | |
State | ||
Income Tax Disclosure [Line Items] | ||
Net operating loss carryforwards | 1,808,500,000 | $ 1,794,200,000 |
Research and development tax credit carryforwards | $ 2,900,000 |
X | ||||||||||
- Definition Deferred income tax amortization. No definition available.
|
X | ||||||||||
- Definition Deferred Tax Asset, Increase (Decrease), Amount No definition available.
|
X | ||||||||||
- Definition Income tax disclosure. No definition available.
|
X | ||||||||||
- Definition Tax cuts and jobs act of 2017 operating loss carry forwards indefinitely. No definition available.
|
X | ||||||||||
- Definition Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|